Key Events This Week
4 May: Intraday high surge to Rs.797.35 (+7.25%)
5 May: Strong price rally closing at Rs.805.70 (+8.26%)
6 May: Partial recovery to Rs.788.50 (+2.15%)
7 May: Decline to Rs.776.60 (-1.51%)
8 May: Week closes at Rs.766.80 (-1.26%)

Aarti Pharmalabs Ltd is Rated Sell
2026-05-08 10:10:44Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 Apr 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 08 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, returns, and overall outlook.
Read full news article
Aarti Pharmalabs Ltd Sees Technical Momentum Shift Amid Strong Price Rally
2026-05-05 08:08:04Aarti Pharmalabs Ltd has exhibited a notable shift in price momentum, moving from a mildly bearish technical trend to a sideways stance, supported by a blend of bullish and bearish signals across key indicators. The stock’s recent surge of 8.26% in a single day to ₹805.70 reflects renewed investor interest, yet technical analysis reveals a complex picture that demands careful scrutiny.
Read full news article
Aarti Pharmalabs Ltd Surges 7.25% to Day's High of Rs 797.35 — Outperforms Sector by 6.42 Percentage Points
2026-05-04 14:16:03The Sensex gained a modest 0.44% on 4 May 2026, while Aarti Pharmalabs Ltd surged 7.25%, outperforming its Pharmaceuticals & Biotechnology sector by 6.42 percentage points. This sharp single-session advance stands out as a distinctly stock-specific event amid a broadly steady market backdrop.
Read full news article
Aarti Pharmalabs Ltd is Rated Sell
2026-04-27 10:11:18Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.
Read full news articleAarti Pharmalabs Gains 1.10%: Technical Shift and Financial Challenges Shape Week
2026-04-18 11:01:01
Key Events This Week
13 Apr: Stock opens at Rs.693.75, gains 0.69% despite Sensex decline
15 Apr: MarketsMOJO upgrades rating to Sell; stock rises 1.27%
16 Apr: Technical momentum shifts; stock dips 0.44% amid mixed signals
17 Apr: Week closes at Rs.696.60, down 0.41% on the day

Aarti Pharmalabs Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges
2026-04-16 08:49:39Aarti Pharmalabs Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 15 April 2026, driven primarily by a shift in technical indicators despite ongoing financial challenges. The company’s Mojo Score now stands at 31.0, reflecting a cautious but slightly more favourable outlook amid persistent operational headwinds and valuation considerations.
Read full news articleBoard Meeting Intimation for Approval Of The Audited Financial Results For The Quarter And Financial Year Ended March 31 2026 And Recommendation Of Final Dividend If Any.
11-May-2026 | Source : BSEAarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 inter alia to consider and approve The Audited Financial Results for the quarter and financial year ended March 31 2026 and recommendation of Final Dividend if any.
Announcement under Regulation 30 (LODR)-Newspaper Publication
07-Apr-2026 | Source : BSENewspaper Advertisement for the Second 100-Day Campaign - Saksham Niveshak
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
07-Apr-2026 | Source : BSEPlease find our intimation on captioned subject
Corporate Actions
18 May 2026
Aarti Pharmalabs Ltd has declared 30% dividend, ex-date: 16 Feb 26
No Splits history available
No Bonus history available
No Rights history available







